[HTML][HTML] COVID-19: Not a thrombotic disease but a thromboinflammatory disease

S He, M Blombäck, H Wallén - Upsala Journal of Medical Sciences, 2024 - ncbi.nlm.nih.gov
Abstract While Coronavirus Disease in 2019 (COVID-19) may no longer be classified as a
global public health emergency, it still poses a significant risk at least due to its association …

Thrombomodulin Resistance: a Novel Prothrombotic Pathway in Covid-19

A Marco-Rico, A Montaño, F López-Jaime… - 2024 - researchsquare.com
Hypercoagulability and endothelial dysfunction are strongly involved in the worsening of the
clinical condition in COVID-19 patients. In severe cases, the inflammatory process triggers …

Thrombin generation assay in COVID-19 patients shows a hypocoagulable pattern

GL Tiscia, D Colaizzo, A De Laurenzo… - … and Vascular Biology, 2024 - btvb.org
Patients with COVID-19 often exhibit coagulopathy, which can significantly impact
prognosis. Therefore, investigating coagulation in this context is clinically relevant. The …

CHARACTERISTICS OF THE HOSPITALIZATION PERIOD IN PATIENTS WHO DIED AS A RESULT OF COVID-19 WITH ACUTE CARDIOVASCULAR …

VM Matskevych - Art of Medicine, 2024 - art-of-medicine.ifnmu.edu.ua
Мета. визначити несприятливі чинники ризику у госпіталізованих пацієнтів з
летальними наслідками коронавірусної хвороби-2019 та гострими серцево-судинними …